{
  "drug_id": "DF09C894FE9",
  "canonical_name": "vm202",
  "total_pmids": 2,
  "evidence_count": {
    "benefit": 1,
    "harm": 0,
    "neutral": 0,
    "unknown": 1
  },
  "evidence_blocks": [
    {
      "pmid": "39778757",
      "title": "Hepatocyte growth factor for walking performance in peripheral artery disease.",
      "direction": "unknown",
      "model": "unknown",
      "endpoint": "unknown",
      "claim": "VM202 is a plasmid encoding two isoforms of hepatocyte growth factor. In preclinical studies, hepatocyte growth factor stimulated angiogenesis and muscle regeneration. This preliminary clinical trial ",
      "confidence": "medium"
    },
    {
      "pmid": "21430785",
      "title": "Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.",
      "direction": "benefit",
      "model": "unknown",
      "endpoint": "unknown",
      "claim": "We aimed to evaluate in a phase I dose-escalation study, the safety of intramuscular injections of a novel non-viral plasmid DNA expressing two isoforms of human hepatocyte growth factor (HGF) (VM202)",
      "confidence": "medium"
    }
  ],
  "top_pmids": [
    "39778757",
    "21430785"
  ]
}